Gabapentin: Possible Misuse Leads to Scheduling in Kentucky

Activity Details
  • Credit Amounts:
    • CME: 0.75
    • CPE: 0.75
    • CNE: 0.75
    • Other: 0.75
    • CDE: 0.75
    • CPHCE: 1.00
  • Cost: Free
  • Release: May 19, 2020
  • Expires: Jul 20, 2022
  • Estimated Time to Complete:
    45 Minutes
  • System Requirements:
  • Average User Rating:
    (6 Ratings)

Faculty

Patricia R.  Freeman Patricia R. Freeman, RPh, PhD, FAPhA
Associate Professor, Pharmacy Practice and Science
Director, Center for the Advancement of Pharmacy Practice (CAPP)
Faculty Associate, Institute for Pharmaceutical Outcomes and Policy (IPOP)
University of Kentucky College of Pharmacy
Lexington, Kentucky

Needs Statement

Concerns about abuse and diversion of gabapentin have been raised in many states, with some states considering listing gabapentin as a “drug of concern,” reportable to their prescription drug monitoring programs (PDMPs), while others have proposed reclassifying the medication as a controlled substance.

Target Audience

Health care professionals/prescribers including physicians, physician assistants, nurses, advance practice registered nurses, pharmacists, dentists, dental hygienists, social workers, counselors, and any others interested in the prevention of and treatment for substance abuse disorder and sustained recovery.

Objectives

Upon the completion of this activity, participants will be able to:

  • Discuss current evidence regarding gabapentin misuse and diversion
  • Discuss results of survey of Kentucky pharmacists regarding gabapentin misuse and regulation
  • Describe gabapentin prescribing variations in Kentucky after reclassification as a Schedule V controlled substance

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

This training has been approved by the KBML as meeting the statutory requirements of HB1.

ACGME Competencies

  • Patient care

CPE
ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0022-9999-19-106-H01-P and will award 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

CNE
The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

This educational activity is offered for a maximum of 0.75 ANCC contact hours.

Provider #: 0041. In order to receive credit, participants complete this CNE activity and submit a credit application and evaluation form online. Certificates may be printed once the evaluation is completed.

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

CDE
This online course meets regulatory requirements for 0.75 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

CPHCE
University of Kentucky College of Public Health certifies that this educational activity was designated for 1.00 hour of Public Health Continuing Education (CPHCE) credit. This course is approved for continuing education by the University of Kentucky College of Public Health. ()

Faculty Disclosure

No speakers or planners have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speaker. In some cases, presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. The speaker will inform the audience when discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.